Benzinga Pro's Top 5 Stocks To Watch For Tuesday, Mar. 2, 2021: BMY, MRK, GILD, BHSE, VUZI

Author: Benzinga Newsdesk | March 02, 2021 09:51am

Today's 5 Stock Ideas:

Bristol-Myers Squibb (BMY) - Cathie Wood of ARK Invest purchased nearly $15 million in the stock on Monday. Wood will appear on Benzinga's YouTube show "The Raz Report" on Wednesday around 2 p.m. EST. Register early for the interview and you could win a chance to ask Cathie questions during the interview. Click here to register.
Merck (MRK) - Shares were up a half percent in pre-market trade following news the Biden Administration signed a deal with Merck to help make Johnson & Johnson's (JNJ) COVID-19 vaccine.
Gilead Sciences (GILD) - The FDA will host an Advisory Committee meeting on Friday to vote on the company's Yescarta as a treatment for certain types of lymphoma. FDA AdCom meetings generally create more volatility in a stock.
Bull Horn Holdings (BHSE) - Company CEO, Robert Striar, will appear on Benzinga's "SPACs Attack" YouTube show around 11:15 a.m. EST Tuesday. Bull Horn is a special purpose acquisition corporation (SPAC) that does not yet have an expected merger partner.
Vuzix (VUZI) - Shares rallied more than 25% on Monday following news the company's M400 and M4000 Smart Glasses now support Microsoft Teams. On Friday of last week, Cathie Wood purchased about $1.5 million in the company's stock. Vuzix is scheduled to report Q4 results on Monday, Mar. 15, 2021 after market close.